Abstract:Background and Aim: Esomeprazole is the S‐isomer of omeprazole, with a stronger acid suppressive effect than omeprazole. This open, randomized crossover study was designed to evaluate the effect of esomeprazole and another proton‐pump inhibitor, rabeprazole, on intragastric pH in healthy Chinese. Methods: Thirty‐six healthy volunteers (26 men and 10 women, aged between 20 and 31 years) were enrolled. Subjects were given either esomeprazole 40 mg ( n = 18) or rabeprazole 10 mg ( n = 18) orally once daily for 5 days during the first dosing period, then the other medicine at the set dosage for the second dosing period. The two periods were separated by a 14‐day washout phase. The doses were chosen according to the State Food and Drug Administration of China for the treatment of acid‐related diseases. Intragastric pH was continuously monitored for 24 h on days 1 and 5 of each dosing period. CYP2C19 genotypes were analyzed to identify the extensive metabolizers (EM) and poor metabolizers (PM). Results: The percentage of time with intragastric pH >4 was significantly higher ( P < 0.001) in subjects receiving esomeprazole than in those receiving rabeprazole in the first 4 h after administration of the first dose (70.65% vs 44.87%), at 24 h on day 1 (73.7% vs 54.8%) and at 24 h on day 5 (84.2% vs 76.2%). The median intragastric pH was also higher in subjects receiving esomeprazole than in those receiving rabeprazole in the first 6 h, day 1 and day 5 ( P ≤ 0.001). The percentage of subjects with intragastric pH >4 for at least 16 h on day 1 (63.9% vs 33.3%) and on day 5 (88.9% vs 61.1%) was higher after administration of esomeprazole than after rabeprazole (both P < 0.05). On genotype analysis, 28 of the subjects were EM and eight were PM. Those who were PM tended to have a higher, albeit not statistically significant, percentage of time with intragastric pH >4 and the median 24‐h intragastric pH than those who were EM. Both drugs were well tolerated. Conclusions: Esomeprazole 40 mg orally once daily is more effective and faster in increasing intragastric pH than rabeprazole 10 mg orally once daily, and thus offers a potential for improved efficacy in acid‐related diseases.

Stomach Myoelectrical Changes of Patients with Gastroesophageal Reflux Disease Receiving Omeprazole Treatment

24 H Esophageal Ph Monitoring in Patients with Gastroesophageal Reflux-Induced Cough Treated with Omeprazole

Observation on the efficacy of the treatment of reflux esophagitis with omeprazole.

Effect of Omeprazole in treating peptic ulcers of children

Clinical Investigation of Paryngolaryngitis As Extra-Esophageal Symptoms of Gastroesophageal Reflux Disease

Efficacy and Safety of Esomeprazole for the Treatment of Reflux Symptoms in Patients with Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis

The Effect of Esomeprazole on Reflux Esophagitis

The treatment efficacy of adding prokinetics to PPIs for gastroesophageal reflux disease: a meta-analysis

Relationship Between Symptom Response and Esophageal Ph Level on Standard Dose of Esomeprazole Treatment for Gastroesophageal Reflux Disease.

[Changes of Intercellular Spaces of Esophageal Epithelium in Patients with Gastroesophageal Reflux Disease Before and after Esomeprazole Treatment].

The Effect of Low-Dose Omeprazole on 24-Hour Intragastric Ph in Healthy Human Subjects

The Safety and Efficacy of Peroral Endoscopic Cardial Constriction in Gastroesophageal Reflux Disease

The effect of low-dose omeprazole on ulcer-like functional dyspepsia and on 24 h intragastric pH

Dilated Intercellular Spaces in Gastroesophageal Reflux Disease Patients and the Changes of Intercellular Spaces after Omeprazole Treatment

[The Changes of Esophageal Epithelial Intercellular Spaces Before and after Omeprazole Treatment in Erosive Esophagitis].

Comparative Effectiveness And Tolerability Of Esomeprazole And Omeprazole In Gastroesophageal Reflux Disease: A Systematic Review And Meta-Analysis

Analysis of the Effect of Omeprazole and Tegaserod on Non-Erosive Reflux Disease

Analysis of 36 Cases of Refractory Gastroesophageal Reflux Disease with Impedance-pH Monitoring

<TITLE>COMPARATIVE EFFECTS OF ESOMEPRAZOLE AND OMEPRAZOLE IN TREATING REFLUX ESOPHAGITIS OF THE AGED

Esomeprazole for gastroesephageal reflux disease: a systematic review

Effect of Esomeprazole and Rabeprazole on Intragastric Ph in Healthy Chinese: an Open, Randomized Crossover Trial